MeiraGTx Holdings MGTX
NASDAQ MGTX
$13.89 -0.08 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

MeiraGTx Holdings (MGTX) Other Accumulated Expenses (2017 - 2026)

MeiraGTx Holdings' (MGTX) quarterly Other Accumulated Expenses came in at $2.6 million in Q4 2025, up 191.25% YoY from $903000.0 in Q4 2024, and down 90.69% on a QoQ basis from $28.2 million in Q3 2025.

Analysis

MeiraGTx Holdings (MGTX) Other Accumulated Expenses (2017 - 2026) Analysis & Trends

MeiraGTx Holdings (MGTX) has 9 years of Other Accumulated Expenses data on file, last reported at $2.6 million in Q4 2025.

  • Quarterly Other Accumulated Expenses rose 191.25% year-over-year to $2.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.6 million (up 191.25% YoY) and the FY2025 annual result came in at $2.6 million, up 191.25% from the prior year.
  • Other Accumulated Expenses declined to $2.6 million in Q4 2025, from $28.2 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $28.2 million in Q3 2025 to a low of $134000.0 in Q2 2021.
  • A 5-year average of $2.1 million and a median of $449000.0 in 2021 frame the typical range for Other Accumulated Expenses.
  • The widest YoY moves for Other Accumulated Expenses: up 5783.54% in 2025, down 84.71% in 2025.
  • Tracing MGTX's Other Accumulated Expenses over 5 years: stood at $456000.0 in 2021, then surged by 104.39% to $932000.0 in 2022, then jumped by 37.12% to $1.3 million in 2023, then dropped by 29.34% to $903000.0 in 2024, then jumped by 191.25% to $2.6 million in 2025.
  • The last three Other Accumulated Expenses figures came in at $2.6 million (Q4 2025), $28.2 million (Q3 2025), and $160000.0 (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 MeiraGTx Holdings 1.27 Bn 1.13 Bn 315.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.11 Mn
Dec 31, 2025 50.28 Mn
Sep 30, 2025 28.24 Mn
Jun 30, 2025 6.81 Mn
Mar 31, 2025 580,000.00
Dec 31, 2024 2.25 Mn
Sep 30, 2024 1.28 Mn
Jun 30, 2024 970,000.00
Mar 31, 2024 1.01 Mn
Dec 31, 2023 1.28 Mn
Sep 30, 2023 2.48 Mn
Jun 30, 2023 2.23 Mn
Mar 31, 2023 2.57 Mn
Dec 31, 2022 6.63 Mn
Sep 30, 2022 3.36 Mn
Jun 30, 2022 983,000.00
Mar 31, 2022 354,000.00
Dec 31, 2021 456,000.00
Sep 30, 2021 328,000.00
Jun 30, 2021 134,000.00